We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Pioneering Hospital Group to Build New Medical Center in Dubai

By LabMedica International staff writers
Posted on 24 Feb 2014
Saudi-based Dr. More...
Soliman Fakeeh Hospital (DSFH; Jeddah, Saudi Arabia) has announced plans to build, at an estimated AED 1 billion, a university and hospital in Dubai (UAE) Silicon Oasis (DSO). DSFH is one of the largest private hospitals in the Middle East with a total bed capacity of 600. DSFH has been a leader that has helped advance by leaps the standards of healthcare delivery in the Saudi Arabia and in the region.

DSFH's project in Dubai is expected to boost medical tourism in the United Arab Emirates (UAE) while addressing the shortage of skilled healthcare staff in the region. Construction will be carried out in phases with the 300-bed hospital scheduled to be completed by 2017, and the medical university by 2019. Built across 150,000 square meters, the hospital university project is expected to offer 4,000 new jobs, according to DSFH.

“The initiative is also a step forward in the implementation of the strategy of the Executive office to make Dubai a hub for medical tourism,” said Dr. Mohammed Al Zarooni, vice chairman and the CEO of the DSO Authority. “Recent statistics show that the number of medical tourists receiving treatment is estimated to increase by 15% each year. Additionally, healthcare spending in the UAE is expected to reach AED 40 billion by 2015, while medical tourists are set to cross the 20 million mark for the same period.” Also, a recent Ernst & Young report on the Gulf Cooperation Council (GCC) countries' healthcare industry called for more skilled local professionals to reduce reliance on expatriate staff, and noted that the region’s healthcare industry is seeing a rise in the number of private investors.

The new hospital, offering secondary and tertiary medical service, will mainly target the growing residence community in DSO and neighboring areas. The 300-bed facility is expected to cater to around 700,000 patients a year, with an estimated 40,000 admissions and 20,000 surgical operations.

Fakeeh Medical University (FMU), which will be built alongside the hospital, will offer instructions in fields such as medicine, nursing, laboratory sciences, radiology, physiotherapy, dentistry, clinical pharmacy, and health policy and management. The project will also include a basic sciences research and development center to develop innovations in the medical field. To encourage collaboration between medical professionals, FMU will partner with local universities, including the Rochester Institute of Technology in DSO; American University of Sharjah; Al Ain University and Dubai Academic City.

“This project will certainly tick all the boxes through value health treatments, best medical advice, job creation, and most importantly the creation of a dependable knowledge in the health field that will benefit this region,” said Dr. Al Zarooni.

Related Links:

Dr. Soliman Fakeeh Hospital


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.